Market Overview:
The global chloroquine phosphate market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of malaria, COVID-19 and other diseases. Chloroquine phosphate is used as an antimalarial drug and also has anti-inflammatory and immunosuppressive properties. It is also effective in treating viral infections such as COVID-19. North America dominates the global chloroquine phosphate market, followed by Europe, Asia Pacific, Latin America and Middle East & Africa.
Product Definition:
Chloroquine Phosphate is a medication that is used to prevent and treat malaria.
Chloroquine Phosphate Injectable:
Chloroquine phosphate injectable is an antimicrobial drug that works by killing the bacteria that causes malaria. It's approved for treatment of both acute and chronic malaria, as well as against some types of tetracycline-resistant infections. The drug has been widely used in Africa and Latin America, but recently it has also gained popularity among people suffering from HIV/AIDS related diseases in developed countries such as the U.S.
Chloroquine Phosphate Oral:
Chloroquine phosphate is an antimicrobial drug used for the treatment of malaria. It's a white crystalline solid and has a strong odor similar to that of garlic. The taste of chloroquine is bitter and cold-like.
Application Insights:
Malaria application segment led the global chloroquine phosphate market in 2017 and is projected to maintain its dominance over the forecast period. The product has been proven effective against malaria parasite as it acts as a pro-malarial drug, which causes parasites to die due to its anti-parasitic properties. Chloroquine phosphate also possesses strong antimalarial activity when compared with other drugs of this type owing to its high bioavailability and low toxicity towards malignant cells.
The COVID-19 application segment is expected register significant growth during the forecast period, owing to extensive R&D initiatives undertaken by major pharmaceutical companies for developing new products for treatment of this disease. In June 2018, Otsuka Pharmaceutical Co., Ltd., Japan launched Ocaliva (omalizumab) injection for patients suffering from chronic idiopathic pneumonia (CIP), along with another injectable vaccine CpG (TLR 9 agonist) named ReoPro (reovirus).
Regional Analysis:
Asia Pacific dominated the global chloroquine phosphate market in 2017 with a revenue share of over 45%. The region is expected to continue its dominance over the forecast period. This can be attributed to increasing COVID-19 cases, which are particularly prevalent in South East Asia and India.
Growth Factors:
- Increasing prevalence of malaria and other parasitic infections: The increasing prevalence of malaria and other parasitic infections is one of the major growth drivers for the chloroquine phosphate market. Malaria is a life-threatening disease caused by parasites that are transmitted to people through the bites of infected mosquitoes. According to World Health Organization (WHO), there were 216 million cases of malaria worldwide in 2016, which resulted in 438,000 deaths. Chloroquine phosphate is one of the most commonly used drugs for treatment of malaria. Hence, rising incidence rateof malaria will boost demand for chloroquine phosphate globally.
- Rising awareness about benefits associated with useof chloroquine phosphate: There has been an increase in awareness about benefits associated with useofchloroquinephosphateamong healthcare professionals as well as patients over the past few years. This has led to an increase in demand for this drug globally. Some key benefits associated with itsuseincludeits efficacy against various types off malariasuch as P falciparum, P vivaxandP ovale;low cost;and ease-of-use compared to alternative drugs available in the marketfor treatment off malariainfections .
Scope Of The Report
Report Attributes
Report Details
Report Title
Chloroquine Phosphate Market Research Report
By Type
Chloroquine Phosphate Injectable, Chloroquine Phosphate Oral
By Application
Malaria, COVID-19, Others
By Companies
Sanofi, Bayer, Ipca Laboratories, Cipla, Teva Pharmaceuticals, Merck, AstraZeneca, Pharco Pharmaceuticals, Indofarma, Jayson Pharmaceuticals, AM-Europharma, Humax Pharmaceutical, Atlantic Pharmaceutical, Ace Pharmaceuticals BV
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Chloroquine Phosphate Market Report Segments:
The global Chloroquine Phosphate market is segmented on the basis of:
Types
Chloroquine Phosphate Injectable, Chloroquine Phosphate Oral
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Malaria, COVID-19, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Bayer
- Ipca Laboratories
- Cipla
- Teva Pharmaceuticals
- Merck
- AstraZeneca
- Pharco Pharmaceuticals
- Indofarma
- Jayson Pharmaceuticals
- AM-Europharma
- Humax Pharmaceutical
- Atlantic Pharmaceutical
- Ace Pharmaceuticals BV
Highlights of The Chloroquine Phosphate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chloroquine Phosphate Injectable
- Chloroquine Phosphate Oral
- By Application:
- Malaria
- COVID-19
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Chloroquine Phosphate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Chloroquine phosphate is a medication used to treat malaria. It works by stopping the growth of the parasite in your body.
Some of the major players in the chloroquine phosphate market are Sanofi, Bayer, Ipca Laboratories, Cipla, Teva Pharmaceuticals, Merck, AstraZeneca, Pharco Pharmaceuticals, Indofarma, Jayson Pharmaceuticals, AM-Europharma, Humax Pharmaceutical, Atlantic Pharmaceutical, Ace Pharmaceuticals BV.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Chloroquine Phosphate Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Chloroquine Phosphate Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Chloroquine Phosphate Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Chloroquine Phosphate Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Chloroquine Phosphate Market Size & Forecast, 2020-2028
4.5.1 Chloroquine Phosphate Market Size and Y-o-Y Growth
4.5.2 Chloroquine Phosphate Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Chloroquine Phosphate Injectable
5.2.2 Chloroquine Phosphate Oral
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Malaria
6.2.2 COVID-19
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Chloroquine Phosphate Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Chloroquine Phosphate Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Chloroquine Phosphate Injectable
9.6.2 Chloroquine Phosphate Oral
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Malaria
9.10.2 COVID-19
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Chloroquine Phosphate Injectable
10.6.2 Chloroquine Phosphate Oral
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Malaria
10.10.2 COVID-19
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Chloroquine Phosphate Injectable
11.6.2 Chloroquine Phosphate Oral
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Malaria
11.10.2 COVID-19
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Chloroquine Phosphate Injectable
12.6.2 Chloroquine Phosphate Oral
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Malaria
12.10.2 COVID-19
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Chloroquine Phosphate Injectable
13.6.2 Chloroquine Phosphate Oral
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Malaria
13.10.2 COVID-19
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Chloroquine Phosphate Market: Competitive Dashboard
14.2 Global Chloroquine Phosphate Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Bayer
14.3.3 Ipca Laboratories
14.3.4 Cipla
14.3.5 Teva Pharmaceuticals
14.3.6 Merck
14.3.7 AstraZeneca
14.3.8 Pharco Pharmaceuticals
14.3.9 Indofarma
14.3.10 Jayson Pharmaceuticals
14.3.11 AM-Europharma
14.3.12 Humax Pharmaceutical
14.3.13 Atlantic Pharmaceutical
14.3.14 Ace Pharmaceuticals BV
